1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Carlo Contreras: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma Ipilimumab, Nivolumab, Pembrolizumab - Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8 | Phase 1 | Recruiting | Carlo Contreras | 36 | 2021-10-20 | 2026-07-13 |
Melanoma (1)
CTLA-4 Antigen (1) · Influenza Vaccines (1) · Ipilimumab (1) · Nivolumab (1) · Opdualag (1) · pembrolizumab (1) · relatlimab (1)
United States (1)